From: Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases
Patient | Affected eye | Treatment | Time from symptom onset to treatment |
---|---|---|---|
1 | OU | Observation | n/a |
2 | OS | Observation | n/a |
3 | OS | Mycophenolate mofetil 500 mg BID, switched to azathioprine 200 mg | 7 years |
4 | OU | Observation | n/a |
5 | OU | Valacyclovir 3 g daily 1 week, 1 g daily 21 days | 2 years |
6 | OD | Beta carotene 25,000 IU, vitamin E 400 IU, lutein 20 mg, CoQ10 300 mg BID, mycophenolate mofetil 1000 mg BID | 9 years |
7 | OS | Observation | n/a |
8 | OS | Observation | n/a |
9 | OU | Observation | n/a |
10 | OS | Mycophenolate mofetil 500 mg | 6 years |
11 | OD | Observation | n/a |
12 | OD | Observation | n/a |
13 | OU | Rituximab (2 doses, 1 g), IV methylprednisolone (2 doses) followed by oral prednisone taper | 41 years |